ACN Stock: Analysts Slash Price Targets on Accenture Even as Buy Ratings Hold
By TrendSpider Editor
Two Wall Street firms have reaffirmed buy ratings on Accenture plc while significantly cutting their price targets, with Morgan Stanley slashing its target from $320 to $240 and TD Cowen trimming from $282 to $275. Accenture shares are trading at $196.20, down 1.28% on the session, and sitting uncom
ACN Stock: Analysts Slash Price Targets on Accenture Even as Buy Ratings Hold
Two Wall Street firms have reaffirmed buy ratings on Accenture plc while significantly cutting their price targets, with Morgan Stanley slashing its target from $320 to $240 and TD Cowen trimming from $282 to $275. Accenture shares are trading at $196.20, down 1.28% on the session, and sitting uncomfortably close to their 52-week low of $188.74. With a 52-week high of $326.73, the stock is trading roughly 40% below its peak, underscoring the magnitude of the drawdown analysts are now pricing in.
Key Drivers of the ACN Stock Move
- Main Catalyst: Morgan Stanley (James Faucette) confirmed a buy rating but cut its price target by $80, from $320 to $240. TD Cowen (Bryan C. Bergin) also confirmed buy but reduced its target from $282 to $275. Neither firm changed their rating stance, but the target reductions signal meaningfully lower near-term expectations for the stock.
- Bull Case: Both analysts are maintaining buy ratings despite the cuts, and the average price target of $257.50 still implies more than 31% upside from the current price of $196.20. The fact that no downgrades were issued across two separate analyst actions suggests conviction in the long-term thesis remains intact.
- Bear Case: Morgan Stanley's new $240 target represents a $80 reduction from $320, a cut of roughly 25% in just one action. The current price of $196.20 is only $7.46 above the 52-week low of $188.74, meaning the stock has very little technical cushion before setting a new annual low. With both firms trimming targets, the direction of estimate revisions is clearly negative.
The forward setup for Accenture is challenging in the near term. The stock is trading near its 52-week floor, and back-to-back price target reductions from two institutional analysts signal that expectations for revenue and earnings growth are being walked back, even if the bullish long-term view is being preserved. Investors will be watching closely for any further analyst commentary or earnings guidance updates that could either stabilize sentiment or accelerate the move toward the 52-week low. A break below $188.74 on elevated volume would represent a technically significant deterioration in the chart structure and could invite additional institutional selling pressure.
ACN Analyst Ratings and Price Targets
- Morgan Stanley (James Faucette): Confirms buy | Price target reduced to $240 from $320
- TD Cowen (Bryan C. Bergin): Confirms buy | Price target reduced to $275 from $282
Total analyst actions: 2. Upgrades: 0. Downgrades: 0. Average price target across both actions: $257.50. While the consensus rating remains at buy, the unanimous direction of target revisions is lower, which is a cautionary signal for investors relying on price target spreads to gauge upside potential.
ACN Seasonality
Mid-March has historically been a transitional period for large-cap technology and IT services stocks, often influenced by fiscal year-end portfolio rebalancing and pre-earnings positioning. For Accenture, which typically reports quarterly results in March and June, analyst target adjustments in this window often reflect updated revenue and margin assumptions ahead of the next earnings print.
ACN Relative Performance
Accenture is currently trading at $196.20, just 4% above its 52-week low of $188.74 and approximately 40% below its 52-week high of $326.73. This positioning near annual lows suggests Accenture has materially underperformed broader market trends over the trailing year. The magnitude of the 52-week range spread of more than $137 per share reflects significant volatility and investor uncertainty about the company's growth trajectory, particularly in an environment where IT services spending visibility has become less predictable. The 1.28% decline on the session is consistent with broader weakness in the stock over recent months, reinforcing the near-52-week-low classification in the data.